US Patent Issued to Max-Planck-Gesellschaft zur Forderung der Wissenschaften on Feb. 10 for "Amphotericin B conjugated stabilized gold nanoparticles and uses thereof" (German Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,453, issued on Feb. 10, was assigned to Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. (Munich).

"Amphotericin B conjugated stabilized gold nanoparticles and uses thereof" was invented by Chandradhish Ghosh (Berlin) and Peter Seeberger (Kleinmachnow, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Conjugates of amphotericin B and gold nanoparticles stabilized with thiohexoses or thiopentoses, and a method to produce said nanoparticles are described. As the conjugates of amphotericin B to the stabilized gold nanoparticles show several advantages over amphotericin B alone, pharmaceutical compositions comprising said nanoparticles...